# Randomised Trial of 3 Artemisinin Combination Therapy for Malaria in Pregnancy

> **NCT01054248** · PHASE3 · COMPLETED · sponsor: **University of Oxford** · enrollment: 511 (actual)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** dihydroartemisinin-piperaquine
- **DRUG:** Artesunate-mefloquine
- **DRUG:** arthemeter-lumefantrin

## Key facts

- **NCT ID:** NCT01054248
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02-16
- **Primary completion:** 2016-09
- **Final completion:** 2016-09
- **Target enrollment:** 511 (ACTUAL)
- **Last updated:** 2022-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01054248

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01054248, "Randomised Trial of 3 Artemisinin Combination Therapy for Malaria in Pregnancy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01054248. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*